BRIEF published on 07/15/2024 at 10:05, 4 months 6 days ago Superdry PLC Shares Now Trading on JP Jenkins Superdry Plc JP Jenkins Share Trading UK Retail
PRESS RELEASE published on 07/15/2024 at 10:00, 4 months 6 days ago Superdry PLC shares now trading on JP Jenkins Superdry PLC shares now trading on JP Jenkins. Superdry PLC, a clothing and accessories company, joins JP Jenkins for trading. CEO Julian Dunkerton and Commercial Director Veronika Oswald comment on the transition Superdry Plc JP Jenkins Julian Dunkerton Share Trading Veronika Oswald
BRIEF published on 07/12/2024 at 08:05, 4 months 9 days ago Superdry plc: Last Day of Dealings and Matched Bargain Facility Shareholders JP Jenkins Delisting Superdry Matched Bargain Facility
PRESS RELEASE published on 07/12/2024 at 08:00, 4 months 9 days ago Superdry plc: Last Day of Dealings and Matched Bargain Facility Superdry plc announces last day of dealings on the Main Market and introduction of Matched Bargain Facility. Shares to be traded on JP Jenkins platform from 15 July 2024 Superdry Plc Securities Trading JP Jenkins Matched Bargain Facility Last Day Of Dealings
BRIEF published on 07/01/2024 at 10:05, 4 months 20 days ago Superdry plc: Total Voting Rights Update Total Voting Rights FCA Disclosure Guidance Superdry
PRESS RELEASE published on 07/01/2024 at 10:00, 4 months 20 days ago Superdry plc: Total Voting Rights Superdry plc confirms total voting rights as 99,253,953 ordinary shares as of 30 June 2024. Shareholders can use this for disclosure notifications under FCA rules Ordinary Shares Superdry Plc Total Voting Rights FCA Rules Disclosure Notifications
BRIEF published on 06/21/2024 at 12:15, 5 months ago Superdry plc: Major Shareholding Notification by Goldman Sachs Voting Rights Financial Instruments Goldman Sachs Shareholding Notification Superdry
PRESS RELEASE published on 06/21/2024 at 12:10, 5 months ago Superdry plc: TR-1: Standard form for notification of major holdings Goldman Sachs Group, Inc. notifies major holdings in Superdry plc on 18-Jun-2024. Total voting rights now at 7.592747%. TR-1 form submitted on 20-Jun-2024 Voting Rights Superdry Plc Major Holdings Goldman Sachs TR-1 Form
BRIEF published on 06/17/2024 at 13:55, 5 months 3 days ago Superdry plc: Result of Sanction Hearing Equity Raise Financial Stability Restructuring Plan Superdry Sanction Hearing
PRESS RELEASE published on 06/17/2024 at 13:50, 5 months 3 days ago Superdry plc: Result of Sanction Hearing Superdry plc announces the Court sanction of the Restructuring Plan, enabling the implementation of Capital and Restructuring Measures for long-term future and profitability Superdry Plc Restructuring Plan Court Sanction Capital And Restructuring Measures Long-term Profitability
Published on 11/21/2024 at 13:30, 19 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 19 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 49 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 49 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 49 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 13 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 33 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 51 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 28 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 4 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 4 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
